Skip to main content
S. 4338 117th Congress Senate

Increasing Transparency in Generic Drug Applications Act

Official title: A bill to provide for increased transparency in generic drug applications.

Introduced: May 26, 2022 Introduced by: Margaret Wood Hassan Democratic · New Hampshire See on congress.gov
Health Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 26, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 26, 2022
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 26, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Increasing Transparency in Generic Drug Applications Act

This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

 Related & companion bills 2
  • HR 7032 Increasing Transparency in Generic Drug Applications Act of 2022
  • HR 7667 Food and Drug Amendments of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Paul, Rand
Kentucky · May 26, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). S. 4338: Increasing Transparency in Generic Drug Applications Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4338/
MLA
"S. 4338: Increasing Transparency in Generic Drug Applications Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4338/.
Bluebook (legal)
S. 4338, 117th Cong. (2026), https://openamerica.io/bill/117-S-4338/.
Markdown link
[S. 4338: Increasing Transparency in Generic Drug Applications Act](https://openamerica.io/bill/117-S-4338/)
Report a problem